Yahoo

FDA’s revolving door reveals Pazdur as new CDER head

Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration (FDA) has a new chief drug regulator, with industry veteran Dr Richard Pazdur taking the helm ...
BioSpace

Capricor Shares Rise as FDA Sets August Decision Date for Rejected Duchenne Therapy

Capricor Therapeutics’ deramiocel was rejected in July 2025, potentially caught between Nicole Verdun, a former top biologics regulator at the FDA, and Vinay Prasad, director of the Center for ...
FierceBiotech

FDA names longtime oncology chief Richard Pazdur as new CDER director

In a surprise move, the FDA has named the longtime leader of its oncology department, Richard Pazdur, M.D., as the new director of the Center for Drug Evaluation and Research, which oversees most ...
BioSpace

FDA’s Hoeg Reportedly Trying To Hire Friend, Fellow Antidepressant Skeptic

Adam Urato, who is currently a vaccine advisor to the CDC, is closely associated with acting CDER director Tracy Beth Høeg ...
Nasdaq

Vanda Seeks FDA Commissioner Review of Outgoing CDER Director's Decision to Uphold Approval of Two Generic Versions of Hetlioz®

WASHINGTON, Aug. 21, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has asked Martin Makary, the Commissioner of the U.S. Food and Drug Administration ...
FiercePharma

FDA leadership churn continues with transfer of OTC drug office director

One day after the FDA’s new director of the Center for Drug Evaluation and Research (CDER), Richard Pazdur, M.D., informed colleagues of his sudden and unexpected retirement, one of his lieutenants ...
BioWorld

Three months later, FDA’s CDER helmless again

The U.S. FDA once again has a leadership gap at the top of its drug center. George Tidmarsh, a biopharma industry veteran who’s helmed CDER for a little more than three months, resigned yesterday ...